BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 26854578)

  • 1. The efficacy of pregabalin in patients with moderate and severe pain due to diabetic peripheral neuropathy.
    Parsons B; Li C
    Curr Med Res Opin; 2016 May; 32(5):929-37. PubMed ID: 26854578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
    Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia.
    Vinik A; Emir B; Parsons B; Cheung R
    Pain Med; 2014 Apr; 15(4):661-70. PubMed ID: 24330406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.
    Arnold LM; McCarberg BH; Clair AG; Whalen E; Thomas N; Jorga A; Pauer L; Vissing R; Park PW
    Postgrad Med; 2017 Nov; 129(8):921-933. PubMed ID: 28967801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin for neuropathic pain in adults.
    Derry S; Bell RF; Straube S; Wiffen PJ; Aldington D; Moore RA
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007076. PubMed ID: 30673120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.
    Lesser H; Sharma U; LaMoreaux L; Poole RM
    Neurology; 2004 Dec; 63(11):2104-10. PubMed ID: 15596757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of pregabalin for treating pain associated with diabetic peripheral neuropathy in subjects with type 1 or type 2 diabetes mellitus.
    Parsons B; Li C; Emir B; Vinik AI
    Curr Med Res Opin; 2018 Nov; 34(11):2015-2022. PubMed ID: 30084288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of pregabalin in patients with spinal cord injury: a pooled analysis.
    Parsons B; Sanin L; Yang R; Emir B; Juhn M
    Curr Med Res Opin; 2013 Dec; 29(12):1675-83. PubMed ID: 23998397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment.
    Edwards RA; Bonfanti G; Grugni R; Manca L; Parsons B; Alexander J
    Adv Ther; 2018 Oct; 35(10):1585-1597. PubMed ID: 30206821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
    Roth T; van Seventer R; Murphy TK
    Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
    Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T
    Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin in patients with inadequately treated painful diabetic peripheral neuropathy: a randomized withdrawal trial.
    Raskin P; Huffman C; Toth C; Asmus MJ; Messig M; Sanchez RJ; Pauer L
    Clin J Pain; 2014 May; 30(5):379-90. PubMed ID: 23887339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Concomitant Pain Medications on Response to Pregabalin in Patients with Postherpetic Neuralgia or Spinal Cord Injury-Related Neuropathic Pain.
    Schug SA; Parsons B; Almas M; Whalen E
    Pain Physician; 2017; 20(1):E53-E63. PubMed ID: 28072797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study.
    Baron R; Brunnmüller U; Brasser M; May M; Binder A
    Eur J Pain; 2008 Oct; 12(7):850-8. PubMed ID: 18242109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
    Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
    J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo-controlled trial.
    Mu Y; Liu X; Li Q; Chen K; Liu Y; Lv X; Xu X; Fan D; Shang N; Yang R; Pauer L; Pan C
    J Diabetes; 2018 Mar; 10(3):256-265. PubMed ID: 28727270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses.
    Freeman R; Durso-Decruz E; Emir B
    Diabetes Care; 2008 Jul; 31(7):1448-54. PubMed ID: 18356405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.